[After care of female genital and breast cancer].
D000359:Aftercare; D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001859:Bone Neoplasms; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D003078:Colchicine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010998:Pleurisy / Q000209:etiology; D011033:Podophyllin / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use
D000470:Alkaloids; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D006728:Hormones; D010455:Peptides; D014747:Vinblastine; D003520:Cyclophosphamide; D011033:Podophyllin; D010447:Peptide Hydrolases; D003078:Colchicine
Ueber die Nachbehandlung des weiblichen Genital--und Brustkrebses.